J Dent Anesth Pain Med.  2019 Aug;19(4):235-238. 10.17245/jdapm.2019.19.4.235.

Anesthetic management in corticobasal degeneration with central sleep apnea: A case report

• Shionoya Y
• Nakamura K
• Sunada K

• KMID: 2456015
• DOI: http://doi.org/10.17245/jdapm.2019.19.4.235

Abstract

Corticobasal degeneration (CBD) is a rare neurodegenerative disease characterized by dystonia, cognitive deficits, and an asymmetric akinetic-rigid syndrome. Little information is available regarding anesthetic management for CBD patients. Our patient was a 55-year-old man with CBD complicated by central sleep apnea (CSA). Due to the risk of perioperative breathing instability associated with anesthetic use, a laryngeal mask airway was used during anesthesia with propofol. Spontaneous respiration was stable under general anesthesia. However, respiratory depression occurred following surgery, necessitating insertion of a nasopharyngeal airway. Since no respiratory depression had occurred during maintenance of the airway using the laryngeal mask, we suspected an upper airway obstruction caused by displacement of the tongue due to residual propofol. Residual anesthetics may cause postoperative respiratory depression in patients with CBD. Therefore, continuous postoperative monitoring of SpOâ‚‚ and preparations to support postoperative ventilation are necessary.

Keyword

Corticobasal Degeneration; Laryngeal Mask Airway; Propofol; Sleep Apnea

MeSH Terms

Airway Obstruction
Anesthesia
Anesthesia, General
Anesthetics
Cognition Disorders
Dystonia
Humans
Laryngeal Masks
Middle Aged
Neurodegenerative Diseases
Propofol
Respiration
Respiratory Insufficiency
Sleep Apnea Syndromes
Sleep Apnea, Central*
Tongue
Ventilation
Anesthetics
Propofol

Reference

1. Armstrong MJ, Litvan I, Lang AE, Bak TH, Bhatia KP, Borroni B, et al. Criteria for the diagnosis of corticobasal degeneration. Neurology. 2013; 80:496–503.

2. Alexander SK, Rittman T, Xuereb JH, Bak TH, Hodges JR, Rowe JB. Validation of the new consensus criteria for the diagnosis of corticobasal degeneration. J Neurol Neurosurg Psychiatry. 2014; 85:925–929.

3. Eckert DJ, Jordan AS, Merchia P, Malhotra A. Central sleep apnea: Pathophysiology and treatment. Chest. 2007; 131:595–607.

4. Murray R, Neumann M, Forman MS, Farmer J, Massimo L, Rice A, et al. Cognitive and motor assessment in autopsy-proven corticobasal degeneration. Neurology. 2007; 68:1274–1283.

5. Whitwell JL, Jack CR Jr, Boeve BF, Parisi JE, Ahlskog JE, Drubach DA, et al. Imaging correlates of pathology in corticobasal syndrome. Neurology. 2010; 75:1879–1887.

6. Hossain AK, Murata Y, Zhang L, Taura S, Saitoh Y, Mizusawa H, et al. Brain perfusion SPECT in patients with corticobasal degeneration: analysis using statistical parametric mapping. Mov Disord. 2003; 18:697–703.

7. Loadsman JA, Hillman DR. Anaesthesia and sleep apnea. Br J Anaesth. 2001; 86:254–266.

8. Kılınç Y, Işık B. Dental treatment of a patient with central sleep apnea and phobic anxiety under sedation: report of a case and clinical considerations. Oral Surg Oral Med Oral Pathol Oral Radiol. 2012; 114:e9–e11.

9. Reves JG, Glass P, Lubarsky DA, McEvoy MD, Martinez-Ruiz R. Intravenous anesthetics. Miller's Anesthesia. 7th ed. Churchill Livingstone;2010. p. 719–768.

10. Muza RT. Central sleep apnoea-a clinical review. J Thorac Dis. 2015; 7:930–937.

11. Roche S, Jacquesson JM, Destée A, Defebvre L, Derambure P, Monaca C. Sleep and vigilance in corticobasal degeneration: a descriptive study. Neurophysiol Clin. 2007; 37:261–264.

12. Brimacombe JR, Berry A. The incidence of aspiration associated with the laryngeal mask airway: a meta-analysis of published literature. J Clin Anesth. 1995; 7:297–305.

13. Bükki J, Nübling G, Lorenzl S. Managing advanced progressive supranuclear palsy and corticobasal degeneration in a palliative care unit: admission triggers and outcomes. Am J Hosp Palliat Care. 2016; 33:477–482.